Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP66277.RAfCsN8U3spQI-apt4oLA_NzJ4lDlnn44ecKetBLZbATs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP66277.RAfCsN8U3spQI-apt4oLA_NzJ4lDlnn44ecKetBLZbATs130_assertion type Assertion NP66277.RAfCsN8U3spQI-apt4oLA_NzJ4lDlnn44ecKetBLZbATs130_head.
- NP66277.RAfCsN8U3spQI-apt4oLA_NzJ4lDlnn44ecKetBLZbATs130_assertion description "[Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP66277.RAfCsN8U3spQI-apt4oLA_NzJ4lDlnn44ecKetBLZbATs130_provenance.
- NP66277.RAfCsN8U3spQI-apt4oLA_NzJ4lDlnn44ecKetBLZbATs130_assertion evidence source_evidence_literature NP66277.RAfCsN8U3spQI-apt4oLA_NzJ4lDlnn44ecKetBLZbATs130_provenance.
- NP66277.RAfCsN8U3spQI-apt4oLA_NzJ4lDlnn44ecKetBLZbATs130_assertion SIO_000772 16804087 NP66277.RAfCsN8U3spQI-apt4oLA_NzJ4lDlnn44ecKetBLZbATs130_provenance.
- NP66277.RAfCsN8U3spQI-apt4oLA_NzJ4lDlnn44ecKetBLZbATs130_assertion wasDerivedFrom gad-20130706 NP66277.RAfCsN8U3spQI-apt4oLA_NzJ4lDlnn44ecKetBLZbATs130_provenance.
- NP66277.RAfCsN8U3spQI-apt4oLA_NzJ4lDlnn44ecKetBLZbATs130_assertion wasGeneratedBy ECO_0000203 NP66277.RAfCsN8U3spQI-apt4oLA_NzJ4lDlnn44ecKetBLZbATs130_provenance.